Mutant monocyte chemoattractant protein 1 protein attenuates migration of and inflammatory cytokine release by macrophages exposed to orthopedic implant wear particles

Journal of Biomedical Materials Research - Part A

Volumn 102, Issue 9, 2014, Pages 3291-3297

  Yao, Zhenyu ^a   Keeney, Michael ^a   Lin, Tzu Hua ^a   Pajarinen, Jukka ^a   Barcay, Katherine ^a   Waters, Heather ^a   Egashira, Kensuke ^b   Yang, Fan ^a,c   Goodman, Stuart ^a,c  

^a STANFORD UNIVERSITY   (United States)

^b Stanford University   (United States)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

chemotaxis; cytokines; inflammation; macrophages; particles

Indexed keywords

BIOASSAY; BIOCHEMISTRY; BODY FLUIDS; CELL CULTURE; ELEMENTARY PARTICLES; PATHOLOGY; PROTEINS;

CHEMOTAXIS; CYTOKINES; DOSE-DEPENDENT MANNER; INFLAMMATION; MESENCHYMAL STEM CELL; PERIPROSTHETIC INFLAMMATION; PROINFLAMMATORY CYTOKINES; TOTAL JOINT REPLACEMENT;

MACROPHAGES;

BIOMATERIAL; CHEMOKINE RECEPTOR CCR2; ENDOTOXIN; GAMMA CHEMOKINE; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; MUTANT PROTEIN; POLY(METHYL METHACRYLATE); RECOMBINANT PROTEIN; CYTOKINE;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL TYPE; CELL VIABILITY; CHEMOTAXIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOSE RESPONSE; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; MACROPHAGE MIGRATION; MESENCHYMAL STEM CELL; MONOCYTE; MOUSE; NONHUMAN; ORTHOPEDIC IMPLANT; OSTEOLYSIS; PROTEIN FUNCTION; RECEPTOR BLOCKING; STIMULATION; ADVERSE EFFECTS; ANIMAL; CELL LINE; CELL SURVIVAL; CYTOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; MUTATION; PROSTHESES AND ORTHOSES;

ANIMALS; CELL LINE; CELL SURVIVAL; CHEMOKINE CCL2; CHEMOTAXIS; CYTOKINES; HUMANS; INFLAMMATION; MACROPHAGES; MICE; MUTATION; POLYMETHYL METHACRYLATE; PROSTHESES AND IMPLANTS;

EID: 84904800925     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34981     Document Type: Article

References (32)

1. Revell PA,. The combined role of wear particles, macrophages and lymphocytes in the loosening of total joint prostheses. J R Soc Interface 2008; 5: 1263-1278.
2. Fuentes ME, Durham SK, Swerdel MR, Lewin AC, Barton DS, Megill JR, Bravo R, Lira SA,. Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J Immunol 1995; 155: 5769-5776.
3. Lu B, Rutledge BJ, Gu L, Fiorillo J, Lukacs NW, Kunkel SL, North R, Gerard C, Rollins BJ,. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 1998; 187: 601-608.
4. Trindade MC, Schurman DJ, Maloney WJ, Goodman SB, Smith RL,. G-protein activity requirement for polymethylmethacrylate and titanium particle-induced fibroblast interleukin-6 and monocyte chemoattractant protein-1 release in vitro. J Biomed Mater Res 2000; 51: 360-368.
5. Shanbhag AS, Kaufman AM, Hayata K, Rubash HE,. Assessing osteolysis with use of high-throughput protein chips. J Bone Joint Surg Am 2007; 89: 1081-1089.
6. Nakashima Y, Sun DH, Trindade MC, Chun LE, Song Y, Goodman SB, Schurman DJ, Maloney WJ, Smith RL,. Induction of macrophage C-C chemokine expression by titanium alloy and bone cement particles. J Bone Joint Surg Br 1999; 81: 155-162.
7. Wang CT, Lin YT, Chiang BL, Lee SS, Hou SM,. Over-expression of receptor activator of nuclear factor-kappaB ligand (RANKL), inflammatory cytokines, and chemokines in periprosthetic osteolysis of loosened total hip arthroplasty. Biomaterials 2010; 31: 77-82.
8. Epstein NJ, Bragg WE, Ma T, Spanogle J, Smith RL, Goodman SB,. UHMWPE wear debris upregulates mononuclear cell proinflammatory gene expression in a novel murine model of intramedullary particle disease. Acta Orthop 2005; 76: 412-420.
9. Epstein NJ, Warme BA, Spanogle J, Ma T, Bragg B, Smith RL, Goodman SB,. Interleukin-1 modulates periprosthetic tissue formation in an intramedullary model of particle-induced inflammation. J Orthop Res 2005; 23: 501-510.
10. Ni W, Egashira K, Kitamoto S, Kataoka C, Koyanagi M, Inoue S, Imaizumi K, Akiyama C, Nishida KI, Takeshita A,. New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice. Circulation 2001; 103: 2096-2101.
11. Zhang Y, Rollins BJ,. A dominant negative inhibitor indicates that monocyte chemoattractant protein 1 functions as a dimer. Mol Cell Biol 1995; 15: 4851-4855.
12. Zhang YJ, Rutledge BJ, Rollins BJ,. Structure/activity analysis of human monocyte chemoattractant protein-1 (MCP-1) by mutagenesis. Identification of a mutated protein that inhibits MCP-1-mediated monocyte chemotaxis. J Biol Chem 1994; 269: 15918-15924.
13. Nich C, Rao AJ, Valladares RD, Li C, Christman JE, Antonios JK, Yao Z, Zwingenberger S, Petite H, Hamadouche M, and others. Role of direct estrogen receptor signaling in wear particle-induced osteolysis. Biomaterials 2013; 34: 641-650.
14. Huang Z, Ma T, Ren PG, Smith RL, Goodman SB,. Effects of orthopedic polymer particles on chemotaxis of macrophages and mesenchymal stem cells. J Biomed Mater Res A 2010; 94: 1264-1269.
15. Ren PG, Lee SW, Biswal S, Goodman SB,. Systemic trafficking of macrophages induced by bone cement particles in nude mice. Biomaterials 2008; 29: 4760-4765.
16. Burton L, Paget D, Binder NB, Bohnert K, Nestor BJ, Sculco TP, Santambrogio L, Ross FP, Goldring SR, Purdue PE,. Orthopedic wear debris mediated inflammatory osteolysis is mediated in part by NALP3 inflammasome activation. J Orthop Res 2013; 31: 73-80.
17. Ingham E, Green TR, Stone MH, Kowalski R, Watkins N, Fisher J,. Production of TNF-alpha and bone resorbing activity by macrophages in response to different types of bone cement particles. Biomaterials 2000; 21: 1005-1013.
18. Lou PJ, Cheng WF, Chung YC, Cheng CY, Chiu LH, Young TH,. PMMA particle-mediated DNA vaccine for cervical cancer. J Biomed Mater Res A 2009; 88: 849-857.
19. Zhang H, Ricciardi BF, Yang X, Shi Y, Camacho NP, Bostrom MG,. Polymethylmethacrylate particles stimulate bone resorption of mature osteoclasts in vitro. Acta Orthop 2008; 79: 281-288.
20. Pearl JI, Ma T, Irani AR, Huang Z, Robinson WH, Smith RL, Goodman SB,. Role of the Toll-like receptor pathway in the recognition of orthopedic implant wear-debris particles. Biomaterials 2011; 32: 5535-5542.
21. Zhu H, Guo ZK, Jiang XX, Li H, Wang XY, Yao HY, Zhang Y, Mao N,. A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone. Nat Protoc 2010; 5: 550-560.
22. Schwarz EM,. What potential biologic treatments are available for osteolysis? J Am Acad Orthop Surg 2008; 16 Suppl 1: S72-S75.
23. Mukaida N, Harada A, Matsushima K,. Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions. Cytokine Growth Factor Rev 1998; 9: 9-23.
24. Rollins BJ,. Chemokines. Blood 1997; 90: 909-928.
25. Wang CT, Lin YT, Chiang BL, Lee SS, Hou SM,. Over-expression of receptor activator of nuclear factor-kappaB ligand (RANKL), inflammatory cytokines, and chemokines in periprosthetic osteolysis of loosened total hip arthroplasty. Biomaterials 2010; 31: 77-82.
26. Gibon E, Ma T, Ren PG, Fritton K, Biswal S, Yao Z, Smith L, Goodman SB,. Selective inhibition of the MCP-1-CCR2 ligand-receptor axis decreases systemic trafficking of macrophages in the presence of UHMWPE particles. J Orthop Res 2012; 30: 547-553.
27. Baqui AA, Meiller TF, Chon JJ, Turng BF, Falkler WA Jr,. Granulocyte-macrophage colony-stimulating factor amplification of interleukin-1 beta and tumor necrosis factor alpha production in THP-1 human monocytic cells stimulated with lipopolysaccharide of oral microorganisms. Clin Diagn Lab Immunol 1998; 5: 341-347.
28. Cavaillon JM, Haeffner-Cavaillon N,. Cytokines and inflammation. Rev Prat 1993; 43: 547-552.
29. van der Poll T, Keogh CV, Guirao X, Buurman WA, Kopf M, Lowry SF,. Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J Infect Dis 1997; 176: 439-444.
30. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, Achong MK,. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998; 101: 311-320.
31. Zhao X, Boenisch O, Yeung M, Mfarrej B, Yang S, Turka LA, Sayegh MH, Iacomini J, Yuan X,. Critical role of proinflammatory cytokine IL-6 in allograft rejection and tolerance. Am J Transplant 2012; 12: 90-101.
32. Duvel A, Frank C, Schnapper A, Schuberth HJ, Sipka A,. Classically or alternatively activated bovine monocyte-derived macrophages in vitro do not resemble CD163/Calprotectin biased macrophage populations in the teat. Innate Immun 2012; 18: 886-896.